glp 1 conference 2025 STRIDE: GLP-1 Boosts Walking Capacity in Diabetic PAD Patients ISPOR 2025: Exploring reasons for

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Medications like Ozempic and Wegovy, part of a class called GLP-1s, have gained popularity for diabetes management and weight loss

Does GLP-1 affect your period

GMP-certified and third-party tested for purity and safety

With a unique blend of whey protein, leucine, and essential vitamins, this innovative product supports muscle and digestive health, offering a convenient nutritional boost for anyone on a fitness journey.

Glucagon-like peptide-1 or GLP-1 is a hormone that is released in your intestines after eating that aids in digestion and absorption